PAREXEL Academy Adds Programs for Students
Three new academic programs have been added to the PAREXEL Academy which span the globe and are designed to prepare students for careers in the biopharmaceutical industry.
Three new academic programs have been added to the PAREXEL Academy which span the globe and are designed to prepare students for careers in the biopharmaceutical industry:
·Bachelor of Science Degree in Clinical Research – Offered in partnership with the Medical School Berlin, in Berlin, Germany, the degree program features courses specific to clinical research. Courses range from ethics in health and medicine to conducting clinical trials. Several courses are taught by PAREXEL experts.
·Postgraduate Certificate in Clinical Trial Management – In cooperation with Salem State University in Salem, Massachusetts, the postgraduate certificate program features a broad-based curriculum in various components of the full life cycle of drug development.
·Joint Program for Clinical Research and Clinical Trial Management – In collaboration with Kyoto Pharmaceutical University in Kyoto, Japan, the joint program provides fifth grade undergraduate students an introductory, seven-week course in clinical research and clinical trial management.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FSP Outsourcing in Clinical Research: Trends and Opportunities
June 9th 2025When drug developers choose the right outsourcing strategies in clinical research, they can gain significant benefits in terms of quality, efficiency, and operational success. In its third annual Functional Service Provider (FSP) Trends Report, Thermo Fisher Scientific’s clinical research business—PPD—gathered insights from 150 global biotech and pharma leaders to determine how FSP models help sponsors address common industry obstacles.
